Post‑translational modifications in diabetic kidney disease (Review)

Martinez Leon V, Hilburg R and Susztak K: Mechanisms of diabetic kidney disease and established and emerging treatments. Nat Rev Endocrinol. 22:21–35. 2026. View Article : Google Scholar

Cheng HT, Xu X, Lim PS and Hung KY: Worldwide epidemiology of diabetes-related end-stage renal disease, 2000-2015. Diabetes Care. 44:89–97. 2021. View Article : Google Scholar

Tonneijck L, Muskiet MH, Smits MM, van Bommel EJ, Heerspink HJ, van Raalte DH and Joles JA: Glomerular hyper-filtration in diabetes: Mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 28:1023–1039. 2017. View Article : Google Scholar : PubMed/NCBI

Ye K, Zhao Y, Huang W and Zhu Y: Sodium butyrate improves renal injury in diabetic nephropathy through AMPK/SIRT1/PGC-1α signaling pathway. Sci Rep. 14:178672024. View Article : Google Scholar

Lee JM, Hammarén HM, Savitski MM and Baek SH: Control of protein stability by post-translational modifications. Nat Commun. 14:2012023. View Article : Google Scholar : PubMed/NCBI

Wu X, Xu M, Geng M, Chen S, Little PJ, Xu S and Weng J: Targeting protein modifications in metabolic diseases: Molecular mechanisms and targeted therapies. Signal Transduct Target Ther. 8:2202023. View Article : Google Scholar : PubMed/NCBI

Burnett G and Kennedy EP: The enzymatic phosphorylation of proteins. J Biol Chem. 211:969–980. 1954. View Article : Google Scholar : PubMed/NCBI

Chen T, Xie S, Cheng J, Zhao Q, Wu H, Jiang P and Du W: AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to glycolysis for tumorigenesis. Nat Commun. 15:6862024. View Article : Google Scholar : PubMed/NCBI

Pearah A, Ramatchandirin B, Liu T, Wolf RM, Ikeda A, Radovick S, Sesaki H, Wondisford FE, O'Rourke B and He L: Blocking AMPKαS496 phosphorylation improves mitochondrial dynamics and hyperglycemia in aging and obesity. Cell Chem Biol. 30:15852023. View Article : Google Scholar

Zhao A, Guo C, Wang L, Chen S, Xu Q, Cheng J, Zhang J, Jiang J, Di J, Zhang H, et al: Xiebai San alleviates acute lung injury by inhibiting the phosphorylation of the ERK/Stat3 pathway and regulating multiple metabolisms. Phytomedicine. 128:1553972024. View Article : Google Scholar : PubMed/NCBI

Liu Z, Yang J, Du M and Xin W: Functioning and mechanisms of PTMs in renal diseases. Front Pharmacol. 14:12387062023. View Article : Google Scholar : PubMed/NCBI

Lu HC, Dai WN and He LY: Epigenetic histone modifications in the pathogenesis of diabetic kidney disease. Diabetes Metab Syndr Obes. 14:329–344. 2021. View Article : Google Scholar : PubMed/NCBI

Du C, Zhu Y, Duan J, Yang Y, Ren Y, Mu L, Yan Z, Li G, Wang H, Shi Y and Yao F: A-485 alleviates fibrosis and apoptosis in kidney by disrupting tandem activation of acetylation and phosphorylation on STAT3. Biomed Pharmacother. 188:1182172025. View Article : Google Scholar : PubMed/NCBI

Natarajan R: Epigenetic mechanisms in diabetic vascular complications and metabolic memory: The 2020 edwin bierman award lecture. Diabetes. 70:328–337. 2021. View Article : Google Scholar : PubMed/NCBI

Kouzarides T: Chromatin modifications and their function. Cell. 128:693–705. 2007. View Article : Google Scholar : PubMed/NCBI

Cheng Y, Chen Y, Wang G, Liu P, Xie G, Jing H, Chen H, Fan Y, Wang M and Zhou J: Protein methylation in diabetic kidney disease. Front Med (Lausanne). 9:7360062022. View Article : Google Scholar : PubMed/NCBI

Mevissen TET and Komander D: Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem. 86:159–192. 2017. View Article : Google Scholar : PubMed/NCBI

Goru SK, Kadakol A and Gaikwad AB: Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy. Pharmacol Res. 120:170–179. 2017. View Article : Google Scholar : PubMed/NCBI

Liu B, Miao X, Shen J, Lou L, Chen K, Mei F, Chen M, Su X, Du X, Zhu Z, et al: USP25 ameliorates diabetic nephropathy by inhibiting TRAF6-mediated inflammatory responses. Int Immunopharmacol. 124:1108772023. View Article : Google Scholar : PubMed/NCBI

Lu D, Zhang Y, Zhu P, Wu J, Yuan C and Ni L: The roles of the ubiquitin-proteasome system in renal disease. Int J Med Sci. 22:1791–1810. 2025. View Article : Google Scholar : PubMed/NCBI

Xu X, Qin Z, Zhang C, Mi X, Zhang C, Zhou F, Wang J, Zhang L and Hua F: TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF-kB/NLRP3 inflammasome pathway. Cell Biol Int. 47:1126–1135. 2023. View Article : Google Scholar : PubMed/NCBI

Zhu S, Hou S, Lu Y, Sheng W, Cui Z, Dong T, Feng H and Wan Q: USP36-mediated deubiquitination of DOCK4 contributes to the diabetic renal tubular epithelial cell injury via Wnt/β-Catenin signaling pathway. Front Cell Dev Biol. 9:6384772021. View Article : Google Scholar

Yang Z, Zhang Y and Sun S: Deciphering the SUMO code in the kidney. J Cell Mol Med. 23:711–719. 2019. View Article : Google Scholar :

Chen ZH, Li D, Zhang JY, Wei BY, Zhao HL, Li P and Chen DQ: SUMOylation and NEDDylation in kidney diseases. Exp Mol Pathol. 144:1050102025. View Article : Google Scholar : PubMed/NCBI

Chatham JC and Patel RP: Protein glycosylation in cardiovascular health and disease. Nat Rev Cardiol. 21:525–544. 2024. View Article : Google Scholar : PubMed/NCBI

Liu Z, Qin Z, Bai W, Wang S, Huang C, Li N, Yan L, Gu Y and Shao F: Integrating bioinformatics and machine learning to elucidate the role of protein glycosylation-related genes in the pathogenesis of diabetic kidney disease. PLoS One. 20:e03296402025. View Article : Google Scholar : PubMed/NCBI

Ren W, Bian Q and Cai Y: Mass spectrometry-based N-glycosylation analysis in kidney disease. Front Mol Biosci. 9:9762982022. View Article : Google Scholar : PubMed/NCBI

Magalhães A, Duarte HO and Reis CA: The role of O-glycosylation in human disease. Mol Aspects Med. 79:1009642021. View Article : Google Scholar : PubMed/NCBI

Liu C, Dong W, Li J, Kong Y and Ren X: O-GlcNAc modification and its role in diabetic retinopathy. Metabolites 2022. 12:7252022.

Ye L, Ding W, Xiao D, Jia Y, Zhao Z, Ao X and Wang J: O-GlcNAcylation: cellular physiology and therapeutic target for human diseases. MedComm (2020). 4:e4562023. View Article : Google Scholar : PubMed/NCBI

Pasupulati AK, Nagati V, Paturi ASV and Reddy GB: Non-enzymatic glycation and diabetic kidney disease. Vitam Horm. 125:251–285. 2024. View Article : Google Scholar : PubMed/NCBI

Ma Y, Wang X, Lin S, King L and Liu L: The potential role of advanced glycation end products in the development of kidney disease. Nutrients. 17:7582025. View Article : Google Scholar : PubMed/NCBI

Parwani K and Mandal P: Role of advanced glycation end products and insulin resistance in diabetic nephropathy. Arch Physiol Biochem. 129:95–107. 2023. View Article : Google Scholar

Chahla C, Kovacic H, Ferhat L and Leloup L: pathological impact of redox post-translational modifications. Antioxid Redox Signal. 41:152–180. 2024. View Article : Google Scholar : PubMed/NCBI

Peleli M, Zampas P and Papapetropoulos A: Hydrogen sulfide and the kidney: Physiological roles, contribution to pathophysiology, and therapeutic potential. Antioxid Redox Signal. 36:220–243. 2022. View Article : Google Scholar : PubMed/NCBI

Vrettou S and Wirth B: S-Glutathionylation and S-Nitrosylation in mitochondria: Focus on homeostasis and neurodegenerative diseases. Int J Mol Sci. 23:158492022. View Article : Google Scholar : PubMed/NCBI

Nakamura T, Oh CK, Zhang X and Lipton SA: Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration. Free Radic Biol Med. 172:562–577. 2021. View Article : Google Scholar : PubMed/NCBI

Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, et al: Metabolic regulation of gene expression by histone lactylation. Nature. 574:575–580. 2019. View Article : Google Scholar : PubMed/NCBI

Wang Y, Li H, Jiang S, Fu D, Lu X, Lu M, Li Y, Luo D, Wu K, Xu Y, et al: The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation. Kidney Int. 106:226–240. 2024. View Article : Google Scholar : PubMed/NCBI

Ye Z, Sun Y, Yang S, Li L, Li B, Xia Y, Yuan T, Yu W, Chen L, Zhou X and Cheng F: Lgals3 promotes calcium oxalate crystal formation and kidney injury through histone lactylation-mediated FGFR4 activation. Adv Sci (Weinh). 12:e24139372025. View Article : Google Scholar : PubMed/NCBI

Qiao J, Tan Y, Liu H, Yang B, Zhang Q, Liu Q, Sun W, Li Z, Wang Q, Feng W, et al: Histone H3K18 and ezrin lactylation promote renal dysfunction in sepsis-associated acute kidney injury. Adv Sci (Weinh). 11:e23072162024. View Article : Google Scholar : PubMed/NCBI

Peng X and Du J: Histone and non-histone lactylation: Molecular mechanisms, biological functions, diseases, and therapeutic targets. Mol Biomed. 6:382025. View Article : Google Scholar : PubMed/NCBI

Wei X, Long M, Yu J and Du Y: The lactate-lactylation axis in renal fibrosis: Potential mechanisms in diabetic kidney disease. Ann Med. 57:25873262025. View Article : Google Scholar : PubMed/NCBI

Shen R, Ruan H, Lin S, Liu B, Song H, Li L and Ma T: Lysine succinylation, the metabolic bridge between cancer and immunity. Genes Dis. 10:2470–2478. 2023. View Article : Google Scholar : PubMed/NCBI

Tan M, Luo H, Lee S, Jin F, Yang JS, Montellier E, Buchou T, Cheng Z, Rousseaux S, Rajagopal N, et al: Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell. 146:1016–1028. 2011. View Article : Google Scholar : PubMed/NCBI

Wan J, Liu H, Chu J and Zhang H: Functions and mechanisms of lysine crotonylation. J Cell Mol Med. 23:7163–7169. 2019. View Article : Google Scholar : PubMed/NCBI

Yang P, Qin Y, Zeng L, He Y, Xie Y, Cheng X, Huang W and Cao L: Crotonylation and disease: Current progress and future perspectives. Biomed Pharmacother. 165:1151082023. View Article : Google Scholar : PubMed/NCBI

Li L, Xiang T, Guo J, Guo F, Wu Y, Feng H, Liu J, Tao S, Fu P and Ma L: Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence. Nat Commun. 15:32002024. View Article : Google Scholar

Zhou T, Cheng X, He Y, Xie Y, Xu F, Xu Y and Huang W: Function and mechanism of histone beta-hydroxybutyrylation in health and disease. Front Immunol. 13:9812852022. View Article : Google Scholar

Alicic RZ, Rooney MT and Tuttle KR: Diabetic kidney disease: Challenges, progress, and possibilities. Clin J Am Soc Nephrol. 12:2032–2045. 2017. View Article : Google Scholar : PubMed/NCBI

Darenskaya M, Kolesnikov S, Semenova N and Kolesnikova L: Diabetic nephropathy: Significance of determining oxidative stress and opportunities for antioxidant therapies. Int J Mol Sci. 24:123782023. View Article : Google Scholar : PubMed/NCBI

Mohandes S, Doke T, Hu H, Mukhi D, Dhillon P and Susztak K: Molecular pathways that drive diabetic kidney disease. J Clin Invest. 133:e1656542023. View Article : Google Scholar : PubMed/NCBI

Jin Q, Liu T, Qiao Y, Liu D, Yang L, Mao H, Ma F, Wang Y, Peng L and Zhan Y: Oxidative stress and inflammation in diabetic nephropathy: Role of polyphenols. Front Immunol. 14:11853172023. View Article : Google Scholar : PubMed/NCBI

Yao L, Liang X, Qiao Y, Chen B, Wang P and Liu Z: Mitochondrial dysfunction in diabetic tubulopathy. Metabolism. 131:1551952022. View Article : Google Scholar : PubMed/NCBI

Hou Y, Wang Q, Han B, Chen Y, Qiao X and Wang L: CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys. Cell Death Dis. 12:5232021. View Article : Google Scholar : PubMed/NCBI

Kim J, Kundu M, Viollet B and Guan KL: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 13:132–141. 2011. View Article : Google Scholar : PubMed/NCBI

Chen C, Ma J, Miao CS, Zhang H, Zhang M, Cao X and Shi Y: Trigonelline induces autophagy to protect mesangial cells in response to high glucose via activating the miR-5189-5p-AMPK pathway. Phytomedicine. 92:1536142021. View Article : Google Scholar : PubMed/NCBI

Jin D, Zhao Y, Sun Y, Xue J, Li X and Wang X: Jiedu Tongluo Baoshen formula enhances renal tubular epithelial cell autophagy to prevent renal fibrosis by activating SIRT1/LKB1/AMPK pathway. Biomed Pharmacother. 160:1143402023. View Article : Google Scholar : PubMed/NCBI

Li A, Yi B, Han H, Yang S, Hu Z, Zheng L, Wang J, Liao Q and Zhang H: Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway. Autophagy. 18:877–890. 2022. View Article : Google Scholar :

Chen Y, Zheng YF, Lin XH, Zhang JP, Lin F and Shi H: Dendrobium mixture attenuates renal damage in rats with diabetic nephropathy by inhibiting the PI3K/Akt/mTOR pathway. Mol Med Rep. 24:5902021. View Article : Google Scholar : PubMed/NCBI

Wang X, Jiang L, Liu XQ, Huang YB, Wang AL, Zeng HX, Gao L, Zhu QJ, Xia LL and Wu YG: Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway. Phytomedicine. 106:1544002022. View Article : Google Scholar : PubMed/NCBI

Wang N and Zhang C: Oxidative stress: A culprit in the progression of diabetic kidney disease. Antioxidants (Basel). 13:4552024. View Article : Google Scholar : PubMed/NCBI

Song S, Qiu D, Wang Y, Wei J, Wu H, Wu M, Wang S, Zhou X, Shi Y and Duan H: TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy. Exp Cell Res. 388:1118622020. View Article : Google Scholar : PubMed/NCBI

Li H, Zhao K and Li Y: Gasdermin D protects mouse podocytes against high-glucose-induced inflammation and apoptosis via the C-Jun N-terminal kinase (JNK) pathway. Med Sci Monit. 27:e9284112021.PubMed/NCBI

Liu Y, Li Y, Xu L, Shi J, Yu X, Wang X, Li X, Jiang H, Yang T, Yin X, et al: Quercetin attenuates podocyte apoptosis of diabetic nephropathy through targeting EGFR signaling. Front Pharmacol. 12:7927772022. View Article : Google Scholar : PubMed/NCBI

Zhai Y, Li D, Wang Z, Shao L, Yin N and Li W: Cortex mori radicis attenuates streptozotocin-induced diabetic renal injury in mice via regulation of transient receptor potential canonical channel 6. Endocr Metab Immune Disord Drug Targets. 22:862–873. 2022. View Article : Google Scholar : PubMed/NCBI

Chen M, Fang Y, Ge Y, Qiu S, Dworkin L and Gong R: The redox-sensitive GSK3β is a key regulator of glomerular podocyte injury in type 2 diabetic kidney disease. Redox Biol. 72:1031272024. View Article : Google Scholar

Feng Q, Yu X, Xie J, Liu F, Zhang X, Li S, Wang Y, Pan S, Liu D and Liu Z: Phillygenin improves diabetic nephropathy by inhibiting inflammation and apoptosis via regulating TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling pathways. Phytomedicine. 136:1563142025. View Article : Google Scholar

Liang LL, He MF, Zhou PP, Pan SK, Liu DW and Liu ZS: GSK3β: A ray of hope for the treatment of diabetic kidney disease. FASEB J. 38:e234582024. View Article : Google Scholar

Wang H, Yu X, Liu D, Qiao Y, Huo J, Pan S, Zhou L, Wang R, Feng Q and Liu Z: VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating Nrf2/HO-1 signaling pathway in diabetic nephropathy. Adv Sci (Weinh). 11:e23055632024. View Article : Google Scholar :

Dong D, Zhang Y, He H, Zhu Y and Ou H: Alpinetin inhibits macrophage infiltration and atherosclerosis by improving the thiol redox state: Requirement of GSk3β/Fyn-dependent Nrf2 activation. FASEB J. 36:e222612022. View Article : Google Scholar

Yu X, Jiang N, Li J, Li X and He S: Upregulation of BRD7 protects podocytes against high glucose-induced apoptosis by enhancing Nrf2 in a GSK-3β-dependent manner. Tissue Cell. 76:1018132022. View Article : Google Scholar

Paeng J, Chang JH, Lee SH, Nam BY, Kang HY, Kim S, Oh HJ, Park JT, Han SH, Yoo TH and Kang SW: Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions. Apoptosis. 19:1678–1690. 2014. View Article : Google Scholar : PubMed/NCBI

Xie J, Yuan Y, Yao G, Yu W and Zhu Q: Role and mechanism of NUP160-regulated autophagy in pathogenesis of diabetic nephropathy. Iran J Kidney Dis. 17:327–334. 2023.PubMed/NCBI

Fang X, Huang W, Sun Q, Zhao Y, Sun R, Liu F, Huang D, Zhang Y, Gao F and Wang B: Melatonin attenuates cellular senescence and apoptosis in diabetic nephropathy by regulating STAT3 phosphorylation. Life Sci. 332:1221082023. View Article : Google Scholar : PubMed/NCBI

Jia J, Tan R, Xu L, Wang H, Li J, Su H, Zhong X, Liu P and Wang L: Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis. Int Immunopharmacol. 135:1123032024. View Article : Google Scholar : PubMed/NCBI

Sun HJ, Xiong SP, Cao X, Cao L, Zhu MY, Wu ZY and Bian JS: Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3. Redox Biol. 38:1018132021. View Article : Google Scholar

Lu J, Chen PP, Zhang JX, Li XQ, Wang GH, Yuan BY, Huang SJ, Liu XQ, Jiang TT, Wang MY, et al: GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity. Theranostics. 11:4728–4742. 2021. View Article : Google Scholar

Jiang W, Xiao T, Han W, Xiong J, He T, Liu Y, Huang Y, Yang K, Bi X, Xu X, et al: Klotho inhibits PKCα/p66SHC-mediated podocyte injury in diabetic nephropathy. Mol Cell Endocrinol. 494:1104902019. View Article : Google Scholar

Wang X, Zhang Y, Chi K, Ji Y, Zhang K, Li P, Fu Z, Wang X, Cui S, Shen W, et al: IGFBP2 induces podocyte apoptosis promoted by mitochondrial damage via integrin α5/FAK in diabetic kidney disease. Apoptosis. 29:1109–1125. 2024. View Article : Google Scholar : PubMed/NCBI

Cao Y, Chen Z, Hu J, Feng J, Zhu Z, Fan Y, Lin Q and Ding G: Mfn2 regulates high glucose-induced MAMs dysfunction and apoptosis in podocytes via PERK pathway. Front Cell Dev Biol. 9:7692132021. View Article : Google Scholar

Tian N, Gao Y, Wang X, Wu X, Zou D, Zhu Z, Han Z, Wang T and Shi Y: Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy. Drug Des Devel Ther. 12:2195–2211. 2018. View Article : Google Scholar : PubMed/NCBI

Uehara R, Yamada E, Okada S, Bastie CC, Maeshima A, Ikeuchi H, Horiguchi K and Yamada M: Fyn phosphorylates transglutaminase 2 (Tgm2) and modulates autophagy and p53 Expression in the development of diabetic kidney disease. Cells. 12:11972023. View Article : Google Scholar : PubMed/NCBI

Khan MF, Mathur A, Pandey VK and Kakkar P: Endoplasmic reticulum stress-dependent activation of TRB3-FoxO1 signaling pathway exacerbates hyperglycemic nephrotoxicity: Protection accorded by Naringenin. Eur J Pharmacol. 917:1747452022. View Article : Google Scholar : PubMed/NCBI

Wu H, Shi Y, Deng X, Su Y, Du C, Wei J, Ren Y, Wu M, Hou Y and Duan H: Inhibition of c-Src/p38 MAPK pathway ameliorates renal tubular epithelial cells apoptosis in db/db mice. Mol Cell Endocrinol. 417:27–35. 2015. View Article : Google Scholar : PubMed/NCBI

Dusabimana T, Kim SR, Park EJ, Je J, Jeong K, Yun SP, Kim HJ, Kim H and Park SW: P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response. Mol Metab. 42:1010892020. View Article : Google Scholar : PubMed/NCBI

Dong R, Zhang X, Liu Y, Zhao T, Sun Z, Liu P, Xiang Q, Xiong J, Du X, Yang X, et al: Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K/AKT/mTOR pathway in diabetic kidney disease. Phytomedicine. 112:1547002023. View Article : Google Scholar : PubMed/NCBI

Lazar AG, Vlad ML, Manea A, Simionescu M and Manea SA: Activated histone acetyltransferase p300/CBP-Related signalling pathways mediate up-regulation of NADPH oxidase, inflammation, and fibrosis in diabetic kidney. Antioxidants (Basel). 10:13562021. View Article : Google Scholar : PubMed/NCBI

Li Y, Li X, He K, Li B, Liu K, Qi J, Wang H, Wang Y and Luo W: C-peptide prevents NF-κB from recruiting p300 and binding to the inos promoter in diabetic nephropathy. FASEB J. 32:2269–2279. 2018. View Article : Google Scholar

Wang M, Huang Z, Li X, He P, Sun H, Peng Y and Fan Q: Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis. Pharmacol Res. 207:1073062024. View Article : Google Scholar : PubMed/NCBI

Lu J, Li XQ, Chen PP, Zhang JX, Liu L, Wang GH, Liu XQ, Jiang TT, Wang MY, Liu WT, et al: Activation of acetyl-CoA synthetase 2 mediates kidney injury in diabetic nephropathy. JCI Insight. 8:e1658172023. View Article : Google Scholar : PubMed/NCBI

Xu J, Deng Y, Ke Y, Zhu Y, Wang P, Yu Q, Li C and Shi B: Mutation of Beclin1 acetylation site at K414 alleviates high glucose-induced podocyte impairment in the early stage of diabetic nephropathy by inhibiting hyperactivated autophagy. Mol Biol Rep. 49:3919–3926. 2022. View Article : Google Scholar : PubMed/NCBI

Li X, Zhang Y, Chen H, Wu Y, Chen Y, Gong S, Liu Y and Liu H: Inhibition of TFEB deacetylation in proximal tubular epithelial cells (TECs) promotes TFEB activation and alleviates TEC damage in diabetic kidney disease. FASEB J. 38:e238842024. View Article : Google Scholar : PubMed/NCBI

Brijmohan AS, Batchu SN, Majumder S, Alghamdi TA, Thieme K, McGaugh S, Liu Y, Advani SL, Bowskill BB, Kabir MG, et al: HDAC6 inhibition promotes transcription factor EB activation and is protective in experimental kidney disease. Front Pharmacol. 9:342018. View Article : Google Scholar : PubMed/NCBI

Liang T, Qi C, Lai Y, Xie J, Wang H, Zhang L, Lin T, Jv M, Li J, Wang Y, et al: HDAC6-mediated α-tubulin deacetylation suppresses autophagy and enhances motility of podocytes in diabetic nephropathy. J Cell Mol Med. 24:11558–11572. 2020. View Article : Google Scholar : PubMed/NCBI

Wang X, Liu J, Zhen J, Zhang C, Wan Q, Liu G, Wei X, Zhang Y, Wang Z, Han H, et al: Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney Int. 86:712–725. 2014. View Article : Google Scholar : PubMed/NCBI

Wang W, Sun W, Cheng Y, Xu Z and Cai L: Role of sirtuin-1 in diabetic nephropathy. J Mol Med (Berl). 97:291–309. 2019. View Article : Google Scholar : PubMed/NCBI

Lo CS, Shi Y, Chenier I, Ghosh A, Wu CH, Cailhier JF, Ethier J, Lattouf JB, Filep JG, Ingelfinger JR, et al: Heterogeneous nuclear ribonucleoprotein F stimulates sirtuin-1 gene expression and attenuates nephropathy progression in diabetic mice. Diabetes. 66:1964–1978. 2017. View Article : Google Scholar : PubMed/NCBI

Liu Y, Liu W, Zhang Z, Hu Y, Zhang X, Sun Y, Lei Q, Sun D, Liu T, Fan Y, et al: Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy. Ren Fail. 43:128–140. 2021. View Article : Google Scholar : PubMed/NCBI

Jiao X, Li Y, Zhang T, Liu M and Chi Y: Role of Sirtuin3 in high glucose-induced apoptosis in renal tubular epithelial cells. Biochem Biophys Res Commun. 480:387–393. 2016. View Article : Google Scholar : PubMed/NCBI

Liu M, Liang K, Zhen J, Zhou M, Wang X, Wang Z, Wei X, Zhang Y, Sun Y, Zhou Z, et al: Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nat Commun. 8:4132017. View Article : Google Scholar : PubMed/NCBI

Liu DW, Zhang JH, Liu FX, Wang XT, Pan SK, Jiang DK, Zhao ZH and Liu ZS: Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1. Exp Mol Med. 51:1–15. 2019. View Article : Google Scholar

Zhao Y, Li D, Zhou P, Zhao Y and Kuang J: microRNA-29b-3p attenuates diabetic nephropathy in mice by modifying EZH2. Hormones (Athens). 22:223–233. 2023. View Article : Google Scholar : PubMed/NCBI

Tang Y, Wan F, Tang X, Lin Y, Zhang H, Cao J and Yang R: Celastrol attenuates diabetic nephropathy by upregulating SIRT1-mediated inhibition of EZH2related wnt/β-catenin signaling. Int Immunopharmacol. 122:1105842023. View Article : Google Scholar

Wang H, Wang J, Ran Q, Leng Y, Liu T, Xiong Z, Zou D and Yang W: Identification and functional analysis of the hub Ferroptosis-Related gene EZH2 in diabetic kidney disease. Int Immunopharmacol. 133:1121382024. View Article : Google Scholar : PubMed/NCBI

Kim D, Ban KY, Lee GH and Jun HS: Lysophosphatidic acid induces podocyte pyroptosis in diabetic nephropathy by an increase of Egr1 expression via downregulation of EzH2. Int J Mol Sci. 24:99682023. View Article : Google Scholar : PubMed/NCBI

Liebisch M and Wolf G: AGE-Induced suppression of EZH2 mediates injury of podocytes by reducing H3K27me3. Am J Nephrol. 51:676–692. 2020. View Article : Google Scholar : PubMed/NCBI

Lin CL, Hsu YC, Huang YT, Shih YH, Wang CJ, Chiang WC and Chang PJ: A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction. EMBO Mol Med. 11:e98282019. View Article : Google Scholar : PubMed/NCBI

Chen H, Huang Y, Zhu X, Liu C, Yuan Y, Su H, Zhang C, Liu C, Xiong M, Qu Y, et al: Histone demethylase UTX is a therapeutic target for diabetic kidney disease. J Physiol. 597:1643–1660. 2019. View Article : Google Scholar

Chen Q, Xie C, Tang K, Luo M, Zhang Z, Jin Y, Liu Y, Zhou L and Kong Y: The E3 ligase Trim63 promotes podocyte injury and proteinuria by targeting PPARα to inhibit fatty acid oxidation. Free Radic Biol Med. 209(Pt 1): 40–54. 2023. View Article : Google Scholar : PubMed/NCBI

Liang L, He M, Zhou P, Pan S, Chen J, Lv L, Hu M, Zhou S, Liu D and Liu Z: c-Cbl induced podocin ubiquitination contributes to the podocytes injury in diabetic nephropathy. FASEB J. 38:e236622024. View Article : Google Scholar : PubMed/NCBI

Xu J, Deng Y, Wang Y, Sun X, Chen S and Fu G: SPAG5-AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5/AKT/mTOR pathway. Cell Prolif. 53:e127382020. View Article : Google Scholar : PubMed/NCBI

Xu Y, Gao H, Hu Y, Fang Y, Qi C, Huang J, Cai X, Wu H, Ding X and Zhang Z: High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway. Exp Cell Res. 382:1114632019. View Article : Google Scholar : PubMed/NCBI

Pontrelli P, Oranger A, Barozzino M, Divella C, Conserva F, Fiore MG, Rossi R, Papale M, Castellano G, Simone S, et al: Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysine 63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy. J Mol Med (Berl). 96:645–659. 2018. View Article : Google Scholar : PubMed/NCBI

Huang Y, Sun Y, Cao Y, Sun H, Li M, You H, Su D, Li Y and Liang X: HRD1 prevents apoptosis in renal tubular epithelial cells by mediating eIF2α ubiquitylation and degradation. Cell Death Dis. 8:32022017. View Article : Google Scholar

Li X, Ma TK, Wen S, Li LL, Xu L, Zhu XW, Zhang CX, Liu N, Wang X and Fan QL: LncRNA ARAP1-AS2 promotes high glucose-induced human proximal tubular cell injury via persistent transactivation of the EGFR by interacting with ARAP1. J Cell Mol Med. 24:12994–13009. 2020. View Article : Google Scholar : PubMed/NCBI

Li X, Ma TK, Wang M, Zhang XD, Liu TY, Liu Y, Huang ZH, Zhu YH, Zhang S, Yin L, et al: YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway. Front Pharmacol. 14:10693482023. View Article : Google Scholar

Cai J, Wei J, Zeng Y, Yi M, Zhou Y, Ai K, Chen W, Liu Y, Chen G, Chen A, et al: UBC9-associated SUMOylation contributes to β-catenin activation and kidney fibrosis. Kidney Int. 108:642–657. 2025. View Article : Google Scholar : PubMed/NCBI

Cai J, Pan J, Zeng Y, Wei J, Yi M, Xiang Y, Liu Z, Duan S, Wang C and Dong Z: SUMOylation protects against sepsis-associated acute kidney injury by stabilizing IκBα. Mol Ther. Oct 27–2025.Epub ahead of print. View Article : Google Scholar

Lizotte F, Rousseau M, Denhez B, Lévesque D, Guay A, Liu H, Moreau J, Higgins S, Sabbagh R, Susztak K, et al: Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease. Kidney Int. 104:787–802. 2023. View Article : Google Scholar : PubMed/NCBI

Wu L, Li O, Zhu F, Wang X, Chen P, Cai G, Chen X and Hong Q: Krϋppel-like factor 15 suppresses renal glomerular mesangial cell proliferation via enhancing P53 SUMO1 conjugation. J Cell Mol Med. 25:5691–5706. 2021. View Article : Google Scholar : PubMed/NCBI

Degrell P, Cseh J, Mohás M, Molnár GA, Pajor L, Chatham JC, Fülöp N and Wittmann I: Evidence of O-linked N-acetylglucosamine in diabetic nephropathy. Life Sci. 84:389–393. 2009. View Article : Google Scholar : PubMed/NCBI

Silva-Aguiar RP, Teixeira DE, Peres RAS, Alves SAS, Novaes-Fernandes C, Dias WB, Pinheiro AAS, Peruchetti DB and Caruso-Neves C: O-linked GlcNAcylation mediates the inhibition of proximal tubule (Na++K+)ATPase activity in the early stage of diabetes mellitus. Biochim Biophys Acta Gen Subj. 1867:1304662023. View Article : Google Scholar

Gellai R, Hodrea J, Lenart L, Hosszu A, Koszegi S, Balogh D, Ver A, Banki NF, Fulop N, Molnar A, et al: Role of O-linked N-acetylglucosamine modification in diabetic nephropathy. Am J Physiol Renal Physiol. 311:F1172–F1181. 2016. View Article : Google Scholar : PubMed/NCBI

Akimoto Y, Miura Y, Toda T, Wolfert MA, Wells L, Boons GJ, Hart GW, Endo T and Kawakami H: Morphological changes in diabetic kidney are associated with increased O-GlcNAcylation of cytoskeletal proteins including α-actinin 4. Clin Proteomics. 8:152011. View Article : Google Scholar

Song S, Hu T, Shi X, Jin Y, Liu S, Li X, Zou W and Wang C: ER stress-perturbed intracellular protein O-GlcNAcylation aggravates podocyte injury in diabetes nephropathy. Int J Mol Sci. 24:176032023. View Article : Google Scholar : PubMed/NCBI

Sugahara S, Kume S, Chin-Kanasaki M, Tomita I, Yasuda-Yamahara M, Yamahara K, Takeda N, Osawa N, Yanagita M, Araki SI and Maegawa H: Protein O-GlcNAcylation is essential for the maintenance of renal energy homeostasis and function via lipolysis during fasting and diabetes. J Am Soc Nephrol. 30:962–978. 2019. View Article : Google Scholar : PubMed/NCBI

Chen CH, Lin KD, Ke LY, Liang CJ, Kuo WC, Lee MY, Lee YL, Hsiao PJ, Hsu CC and Shin SJ: O-GlcNAcylation disrupts STRA6-retinol signals in kidneys of diabetes. Biochim Biophys Acta Gen Subj. 1863:1059–1069. 2019. View Article : Google Scholar : PubMed/NCBI

Qin J, Chen Z, Ye M, Liang L and Ding X: High glucose promotes O-GlcNAcylation of ACSL4 to induce ferroptosis of renal tubular epithelial cell. Autoimmunity. 58:25768812025. View Article : Google Scholar : PubMed/NCBI

Fang M, Kang L, Wang X, Guo X, Wang W, Qin B, Du X, Tang Q and Lin H: Inhibition of core fucosylation limits progression of diabetic kidney disease. Biochem Biophys Res Commun. 520:612–618. 2019. View Article : Google Scholar : PubMed/NCBI

Ferreira MJ, Rodrigues TA, Pedrosa AG, Silva AR, Vilarinho BG, Francisco T and Azevedo JE: Glutathione and peroxisome redox homeostasis. Redox Biol. 67:1029172023. View Article : Google Scholar : PubMed/NCBI

Rashdan NA, Shrestha B and Pattillo CB: S-glutathionylation, friend or foe in cardiovascular health and disease. Redox Biol. 37:1016932020. View Article : Google Scholar : PubMed/NCBI

Guo Y, Liu Y, Zhao S, Xu W, Li Y, Zhao P, Wang D, Cheng H, Ke Y and Zhang X: Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages. Nat Commun. 12:70942021. View Article : Google Scholar : PubMed/NCBI

Lash LH: Renal glutathione: Dual roles as antioxidant protector and bioactivation promoter. Biochem Pharmacol. 228:1161812024. View Article : Google Scholar : PubMed/NCBI

Li SS, Cui N, Yang Y, Trower TC, Wei YM, Wu Y, Zhang S, Jin X and Jiang C: Impairment of the vascular KATP channel imposes fatal susceptibility to experimental diabetes due to multi-organ injuries. J Cell Physiol. 230:2915–2926. 2015. View Article : Google Scholar : PubMed/NCBI

Sampathkumar R, Balasubramanyam M, Sudarslal S, Rema M, Mohan V and Balaram P: Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy. Clin Biochem. 38:892–899. 2005. View Article : Google Scholar : PubMed/NCBI

Li Q, Veron D and Tufro A: S-Nitrosylation of RhoGAP Myosin9A is altered in advanced diabetic kidney disease. Front Med (Lausanne). 8:6795182021. View Article : Google Scholar : PubMed/NCBI

Michelis R, Kristal B, Zeitun T, Shapiro G, Fridman Y, Geron R and Sela S: Albumin oxidation leads to neutrophil activation in vitro and inaccurate measurement of serum albumin in patients with diabetic nephropathy. Free Radic Biol Med. 60:49–55. 2013. View Article : Google Scholar : PubMed/NCBI

Wu M and Ye X: Quercetin-4'-O-β-D-glucopyranoside inhibits podocyte injury by SIRT5-mediated desuccinylation of NEK7. Clin Exp Pharmacol Physiol. 51:e139092024. View Article : Google Scholar

Suk Kang J, Son SS, Lee JH, Lee SW, Jeong AR, Lee ES, Cha SK, Chung CH and Lee EY: Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy. PLoS One. 16:e02506662021. View Article : Google Scholar : PubMed/NCBI

Liu H, Chen W, Lu P, Ma Y, Liang X and Liu Y: Ginsenoside Rg1 attenuates the inflammation and oxidative stress induced by diabetic nephropathy through regulating the PI3K/AKT/FOXO3 pathway. Ann Transl Med. 9:17892021. View Article : Google Scholar

Park HS, Lim JH, Kim MY, Kim Y, Hong YA, Choi SR, Chung S, Kim HW, Choi BS, Kim YS, et al: Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy. J Transl Med. 14:1762016. View Article : Google Scholar : PubMed/NCBI

Huang Q, Ouyang DS and Liu Q: Isoeucommin A attenuates kidney injury in diabetic nephropathy through the Nrf2/HO-1 pathway. FEBS Open Bio. 11:2350–2363. 2021. View Article : Google Scholar : PubMed/NCBI

Garner KL, Betin VMS, Pinto V, Graham M, Abgueguen E, Barnes M, Bedford DC, McArdle CA and Coward RJM: Enhanced insulin receptor, but not PI3K, signalling protects podocytes from ER stress. Sci Rep. 8:39022018. View Article : Google Scholar : PubMed/NCBI

Li L, Zou J, Zhou M, Li H, Zhou T, Liu X, Huang Q, Yang S, Xiang Q and Yu R: Phenylsulfate-induced oxidative stress and mitochondrial dysfunction in podocytes are ameliorated by Astragaloside IV activation of the SIRT1/PGC1α/Nrf1 signaling pathway. Biomed Pharmacother. 177:1170082024. View Article : Google Scholar

Wang X, Gao Y, Tian N, Wang T, Shi Y, Xu J and Wu B: Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT-NF-κB p65 axis. Sci Rep. 9:3232019. View Article : Google Scholar

Lu J, Li XQ, Chen PP, Zhang JX, Li L, Wang GH, Liu XQ, Jiang CM and Ma KL: Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1/ChREBP pathway. Acta Pharmacol Sin. 45:366–377. 2024. View Article : Google Scholar

Ogura Y, Kitada M, Monno I, Kanasaki K, Watanabe A and Koya D: Renal mitochondrial oxidative stress is enhanced by the reduction of Sirt3 activity, in Zucker diabetic fatty rats. Redox Rep. 23:153–159. 2018. View Article : Google Scholar : PubMed/NCBI

Lv T, Lu Y, Liu Y, Feng H, Li C, Sheng W, Cui Z, Zhu S, Gu X, Yang Z and Wan Q: General control of amino acid synthesis 5-like 1-mediated acetylation of manganese superoxide dismutase regulates oxidative stress in diabetic kidney disease. Oxid Med Cell Longev. 2021:66912262021. View Article : Google Scholar : PubMed/NCBI

Chen J, Guo Y, Zeng W, Huang L, Pang Q, Nie L, Mu J, Yuan F and Feng B: ER stress triggers MCP-1 expression through SET7/9-induced histone methylation in the kidneys of db/db mice. Am J Physiol Renal Physiol. 306:F916–F925. 2014. View Article : Google Scholar : PubMed/NCBI

Zhao M, Wang S, Zuo A, Zhang J, Wen W, Jiang W, Chen H, Liang D, Sun J and Wang M: HIF-1α/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury. Cell Mol Biol Lett. 26:402021. View Article : Google Scholar

Siddiqi FS, Majumder S, Thai K, Abdalla M, Hu P, Advani SL, White KE, Bowskill BB, Guarna G, Dos Santos CC, et al: The histone methyltransferase enzyme enhancer of zeste homolog 2 protects against podocyte oxidative stress and renal injury in diabetes. J Am Soc Nephrol. 27:2021–2034. 2016. View Article : Google Scholar

Dai X, Liao R, Liu C, Liu S, Huang H, Liu J, Jin T, Guo H, Zheng Z, Xia M, et al: Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy. Redox Biol. 45:1020332021. View Article : Google Scholar : PubMed/NCBI

Li T, Yu C and Zhuang S: Histone methyltransferase EZH2: A potential therapeutic target for kidney diseases. Front Physiol. 12:6407002021. View Article : Google Scholar : PubMed/NCBI

Wang M, Hu J, Yan L, Yang Y, He M, Wu M, Li Q, Gong W, Yang Y, Wang Y, et al: High glucose-induced ubiquitination of G6PD leads to the injury of podocytes. FASEB J. 33:6296–6310. 2019. View Article : Google Scholar : PubMed/NCBI

Mathur A, Pandey VK, Khan MF and Kakkar P: PHLPP1/Nrf2-Mdm2 axis induces renal apoptosis via influencing nucleo-cytoplasmic shuttling of FoxO1 during diabetic nephropathy. Mol Cell Biochem. 476:3681–3699. 2021. View Article : Google Scholar : PubMed/NCBI

Ye G, Hu ML and Xiao L: Forkhead box A2-mediated lncRNA SOX2OT up-regulation alleviates oxidative stress and apoptosis of renal tubular epithelial cells by promoting SIRT1 expression in diabetic nephropathy. Nephrology (Carlton). 28:196–207. 2023. View Article : Google Scholar

Li S, Lin Z, Xiao H, Xu Z, Li C, Zeng J, Xie X, Deng L and Huang H: Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis. Metabolism. 139:1553782023. View Article : Google Scholar

Chen ZQ, Sun XH, Li XJ, Xu ZC, Yang Y, Lin ZY, Xiao HM, Zhang M, Quan SJ and Huang HQ: Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway. Acta Pharmacol Sin. 41:1587–1596. 2020. View Article : Google Scholar : PubMed/NCBI

Du L, Wang L, Wang B, Wang J, Hao M, Chen YB, Li XZ, Li Y, Jiang YF, Li CC, et al: A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling. Acta Pharmacol Sin. 41:358–372. 2020. View Article : Google Scholar :

Gong W, Chen Z, Zou Y, Zhang L, Huang J, Liu P and Huang H: CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys. Free Radic Biol Med. 115:338–350. 2018. View Article : Google Scholar

Chen J, Ou Z, Gao T, Yang Y, Shu A, Xu H, Chen Y and Lv Z: Ginkgolide B alleviates oxidative stress and ferroptosis by inhibiting GPX4 ubiquitination to improve diabetic nephropathy. Biomed Pharmacother. 156:1139532022. View Article : Google Scholar : PubMed/NCBI

Zhao QX, Yan SB, Wang F, Li XX, Shang GK, Zheng ZJ, Xiao J, Lin ZW, Li CB and Ji XP: STING deficiency alleviates ferroptosis through FPN1 stabilization in diabetic kidney disease. Biochem Pharmacol. 222:1161022024. View Article : Google Scholar : PubMed/NCBI

Kim M, Bae JY, Yoo S, Kim HW, Lee SA, Kim ET and Koh G: 2-Deoxy-d-ribose induces ferroptosis in renal tubular epithelial cells via ubiquitin-proteasome system-mediated xCT protein degradation. Free Radic Biol Med. 208:384–393. 2023. View Article : Google Scholar : PubMed/NCBI

Xu L, Zhou Y, Wang G, Bo L, Jin B, Dai L, Lu Q, Cai X, Hu L, Liu L, et al: The UDPase ENTPD5 regulates ER stress-associated renal injury by mediating protein N-glycosylation. Cell Death Dis. 14:1662023. View Article : Google Scholar : PubMed/NCBI

Jo R, Shibata H, Kurihara I, Yokota K, Kobayashi S, Murai-Takeda A, Mitsuishi Y, Hayashi T, Nakamura T and Itoh H: Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification. Hypertens Res. 46:19–31. 2023. View Article : Google Scholar

Sampathkumar R, Balasubramanyam M, Tara C, Rema M and Mohan V: Association of hypoglutathionemia with reduced Na+/K+ ATPase activity in type 2 diabetes and microangiopathy. Mol Cell Biochem. 282:169–176. 2006. View Article : Google Scholar

Dursun E, Timur M, Dursun B, Süleymanlar G and Ozben T: Protein oxidation in type 2 diabetic patients on hemodialysis. J Diabetes Complications. 19:142–146. 2005. View Article : Google Scholar : PubMed/NCBI

Wang M, Li Q, Wang S, Zuo L, Hai Y, Yuan S, Li X, Huang X, Yang C, Yao L, et al: Astragaloside IV protects renal tubular epithelial cells against oxidative stress-induced injury by upregulating CPT1A-mediated HSD17B10 lysine succinylation in diabetic kidney disease. Phytother Res. 38:4519–4540. 2024. View Article : Google Scholar : PubMed/NCBI

Lin Q, Ma Y, Chen Z, Hu J, Chen C, Fan Y, Liang W and Ding G: Sestrin-2 regulates podocyte mitochondrial dysfunction and apoptosis under high-glucose conditions via AMPK. Int J Mol Med. 45:1361–1372. 2020.PubMed/NCBI

Sun MY, Ye HJ, Zheng C, Jin ZJ, Yuan Y and Weng HB: Astragalin ameliorates renal injury in diabetic mice by modulating mitochondrial quality control via AMPK-dependent PGC1α pathway. Acta Pharmacol Sin. 44:1676–1686. 2023. View Article : Google Scholar : PubMed/NCBI

Yao L, Liang X, Liu Y, Li B, Hong M, Wang X, Chen B, Liu Z and Wang P: Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K/Akt/eNOS signaling pathway in diabetic tubulopathy. Redox Biol. 68:1029462023. View Article : Google Scholar : PubMed/NCBI

Kong Z, Xiao M, Wang B, Zhang W, Che K, Lv W, Wang Y, Huang Y, Zhao H, Zhao Y, et al: Renoprotective effect of isoorientin in diabetic nephropathy via activating autophagy and inhibiting the PI3K-AKT-TSC2-mTOR pathway. Am J Chin Med. 51:1269–1291. 2023. View Article : Google Scholar : PubMed/NCBI

Rousseau M, Denhez B, Spino C, Lizotte F, Guay A, Côté A-M, Burger D and Geraldes P: Reduction of DUSP4 contributes to podocytes oxidative stress, insulin resistance and diabetic nephropathy. Biochem Biophys Res Commun. 624:127–133. 2022. View Article : Google Scholar : PubMed/NCBI

Wang S, Yang Y, He X, Yang L, Wang J, Xia S, Liu D, Liu S, Yang L, Liu W and Duan H: Cdk5-mediated phosphorylation of Sirt1 contributes to podocyte mitochondrial dysfunction in diabetic nephropathy. Antioxid Redox Signal. 34:171–190. 2021. View Article : Google Scholar

Zeng Y, Guo M, Wu Q, Tan X, Jiang C, Teng F, Chen J, Zhang F, Ma X, Li X, et al: Gut microbiota-derived indole-3-propionic acid alleviates diabetic kidney disease through its mitochondrial protective effect via reducing ubiquitination mediated-degradation of SIRT1. J Adv Res. 73:607–630. 2025. View Article : Google Scholar :

Wang F, Xu W, Liu X and Zhang J: Dexmedetomidine ameliorates high glucose-induced epithelial-mesenchymal transformation in HK-2 cells through the Cdk5/Drp1/ROS pathway. Acta Biochim Biophys Sin (Shanghai). 56:71–81. 2024. View Article : Google Scholar :

Chen Z, Ma Y, Yang Q, Hu J, Feng J, Liang W and Ding G: AKAP1 mediates high glucose-induced mitochondrial fission through the phosphorylation of Drp1 in podocytes. J Cell Physiol. 235:7433–7448. 2020. View Article : Google Scholar : PubMed/NCBI

Liu S, Li X, Wen R, Chen L, Yang Q, Song S, Xiao G, Su Z and Wang C: Increased thromboxane/prostaglandin receptors contribute to high glucose-induced podocyte injury and mitochondrial fission through ROCK1-Drp1 signaling. Int J Biochem Cell Biol. 151:1062812022. View Article : Google Scholar : PubMed/NCBI

Wang W, Wang Y, Long J, Wang J, Haudek SB, Overbeek P, Chang BH, Schumacker PT and Danesh FR: Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab. 15:186–200. 2012. View Article : Google Scholar : PubMed/NCBI

Zhu X, Deng Z, Cao Y, Zhou Z, Sun W, Liu C, Fan S and Yin XX: Resveratrol prevents Drp1-mediated mitochondrial fission in the diabetic kidney through the PDE4D/PKA pathway. Phytother Res. 37:5916–5931. 2023. View Article : Google Scholar : PubMed/NCBI

Picca A, Faitg J, Auwerx J, Ferrucci L and D'Amico D: Mitophagy in human health, ageing and disease. Nat Metab. 5:2047–2061. 2023. View Article : Google Scholar : PubMed/NCBI

Li K, Xia X and Tong Y: Multiple roles of mitochondrial autophagy receptor FUNDC1 in mitochondrial events and kidney disease. Front Cell Dev Biol. 12:14533652024. View Article : Google Scholar : PubMed/NCBI

Liu L, Feng D, Chen G, Chen M, Zheng Q, Song P, Ma Q, Zhu C, Wang R, Qi W, et al: Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol. 14:177–185. 2012. View Article : Google Scholar : PubMed/NCBI

Zheng T, Wang HY, Chen Y, Chen X, Wu ZL, Hu QY and Sun H: Src activation aggravates podocyte injury in diabetic nephropathy via suppression of FUNDC1-mediated mitophagy. Front Pharmacol. 13:8970462022. View Article : Google Scholar : PubMed/NCBI

Feng J, Chen Z, Ma Y, Yang X, Zhu Z, Zhang Z, Hu J, Liang W and Ding G: AKAP1 contributes to impaired mtDNA replication and mitochondrial dysfunction in podocytes of diabetic kidney disease. Int J Biol Sci. 18:4026–4042. 2022. View Article : Google Scholar : PubMed/NCBI

Li X, Yang Q, Liu S, Song S and Wang C: Mitochondria-associated endoplasmic reticulum membranes promote mitochondrial fission through AKAP1-Drp1 pathway in podocytes under high glucose conditions. Exp Cell Res. 424:1135122023. View Article : Google Scholar : PubMed/NCBI

Small DM, Morais C, Coombes JS, Bennett NC, Johnson DW and Gobe GC: Oxidative stress-induced alterations in PPAR-γ and associated mitochondrial destabilization contribute to kidney cell apoptosis. Am J Physiol Renal Physiol. 307:F814–F822. 2014. View Article : Google Scholar : PubMed/NCBI

Lee J, Tsogbadrakh B, Yang S, Ryu H, Kang E, Kang M, Kang HG, Ahn C and Oh KH: Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection. Biochem Biophys Res Commun. 534:1040–1046. 2021. View Article : Google Scholar

Pham TK, Nguyen THT, Yun HR, Vasileva EA, Mishchenko NP, Fedoreyev SA, Stonik VA, Vu TT, Nguyen HQ, Cho SW, et al: Echinochrome a prevents diabetic nephropathy by inhibiting the PKC-Iota pathway and enhancing renal mitochondrial function in db/db Mice. Mar Drugs. 21:2222023. View Article : Google Scholar : PubMed/NCBI

Zhou D, Zhou M, Wang Z, Fu Y, Jia M, Wang X, Liu M, Zhang Y, Sun Y, Lu Y, et al: PGRN acts as a novel regulator of mitochondrial homeostasis by facilitating mitophagy and mitochondrial biogenesis to prevent podocyte injury in diabetic nephropathy. Cell Death Dis. 10:5242019. View Article : Google Scholar : PubMed/NCBI

Saxena S, Anand SK, Sharma A and Kakkar P: Involvement of Sirt1-FoxO3a-Bnip3 axis and autophagy mediated mitochondrial turnover in according protection to hyperglycemic NRK-52E cells by Berberine. Toxicol In Vitro. 100:1059162024. View Article : Google Scholar : PubMed/NCBI

Li Q, Liao J, Chen W, Zhang K, Li H, Ma F, Zhang H, Han Q, Guo J, Li Y, et al: NAC alleviative ferroptosis in diabetic nephropathy via maintaining mitochondrial redox homeostasis through activating SIRT3-SOD2/Gpx4 pathway. Free Radic Biol Med. 187:158–170. 2022. View Article : Google Scholar : PubMed/NCBI

Fan Y, Yang Q, Yang Y, Gao Z, Ma Y, Zhang L, Liang W and Ding G: Sirt6 suppresses high glucose-induced mitochondrial dysfunction and apoptosis in podocytes through AMPK activation. Int J Biol Sci. 15:701–713. 2019. View Article : Google Scholar : PubMed/NCBI

Zhang Z, Zhou F, Lu M, Zhang D, Zhang X, Xu S and He Y: WTAP-mediated m6A modification of TRIM22 promotes diabetic nephropathy by inducing mitochondrial dysfunction via ubiquitination of OPA1. Redox Rep. 29:24047942024. View Article : Google Scholar

Lv Z, Wang Z, Hu J, Su H, Liu B, Lang Y, Yu Q, Liu Y, Fan X, Yang M, et al: LncRNA PVT1 induces mitochondrial dysfunction of podocytes via TRIM56 in diabetic kidney disease. Cell Death Dis. 15:6972024. View Article : Google Scholar : PubMed/NCBI

Xiao L and Ye G: RUNX3 alleviates mitochondrial dysfunction and tubular damage by inhibiting TLR4/NF-κB signalling pathway in diabetic kidney disease. Nephrology (Carlton). 29:470–481. 2024. View Article : Google Scholar : PubMed/NCBI

Ji X, Yang X, Gu X, Chu L, Sun S, Sun J, Song P, Mu Q, Wang Y, Sun X, et al: CUL3 induces mitochondrial dysfunction via MRPL12 ubiquitination in renal tubular epithelial cells. FEBS J. 290:5340–5352. 2023. View Article : Google Scholar : PubMed/NCBI

Yang Y, Ren S, Xue J, Dong W, He W, Luo J, Li X, Xu H, Zheng Z, Wang X, et al: DeSUMOylation of RBMX regulates exosomal sorting of cargo to promote renal tubulointerstitial fibrosis in diabetic kidney disease. J Adv Res. 74:175–189. 2024. View Article : Google Scholar : PubMed/NCBI

Pérez-Gallardo RV, Noriega-Cisneros R, Esquivel-Gutiérrez E, Calderón-Cortés E, Cortés-Rojo C, Manzo-Avalos S, Campos-García J, Salgado-Garciglia R, Montoya-Pérez R, Boldogh I and Saavedra-Molina A: Effects of diabetes on oxidative and nitrosative stress in kidney mitochondria from aged rats. J Bioenerg Biomembr. 46:511–518. 2014. View Article : Google Scholar : PubMed/NCBI

Rosca MG, Mustata TG, Kinter MT, Ozdemir AM, Kern TS, Szweda LI, Brownlee M, Monnier VM and Weiss MF: Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol. 289:F420–F430. 2005. View Article : Google Scholar : PubMed/NCBI

Rosca MG, Monnier VM, Szweda LI and Weiss MF: Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal. Am J Physiol Renal Physiol. 283:F52–F59. 2002. View Article : Google Scholar : PubMed/NCBI

Chen J, Feng Q, Qiao Y, Pan S, Liang L, Liu Y, Zhang X, Liu D and Liu Z and Liu Z: ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes. Diabetologia. 67:1429–1443. 2024. View Article : Google Scholar : PubMed/NCBI

Fan Z, Zhang Y, Yuan L, Gao Y, Tian X, Tian J, Wan J, Li B, Wang X, Wang S, et al: LARS1 lactylation inhibits autophagy by activating mTORC1 to promote podocytes injury in diabetic kidney disease. Cell Signal. 134:1119552025. View Article : Google Scholar : PubMed/NCBI

Qian J, Yin S, Ye L, Wang Z, Shu S, Mou Z, Xu M, Chattipakorn N, Liu Z and Liang G: An Indole-2-Carboxamide Derivative, LG4, alleviates diabetic kidney disease through inhibiting MAPK-Mediated inflammatory responses. J Inflamm Res. 14:1633–1645. 2021. View Article : Google Scholar : PubMed/NCBI

Li X, Wang J, Yan J, He JC, Li Y and Zhong Y: Additive renal protective effects between arctigenin and puerarin in diabetic kidney disease. Biomed Pharmacother. 171:1161072024. View Article : Google Scholar : PubMed/NCBI

Xu X, Zhang L, Hua F, Zhang C, Zhang C, Mi X, Qin N, Wang J, Zhu A, Qin Z and Zhou F: FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy. Exp Cell Res. 408:1128632021. View Article : Google Scholar

Ma L, Wu F, Shao Q, Chen G, Xu L and Lu F: Baicalin alleviates oxidative stress and inflammation in diabetic nephropathy via Nrf2 and MAPK signaling pathway. Drug Des Devel Ther. 15:3207–3221. 2021. View Article : Google Scholar : PubMed/NCBI

Li X, Wen J, Dong Y, Zhang Q, Guan J, Liu F, Zhou T, Li Z, Fan Y and Wang N: Wnt5a promotes renal tubular inflammation in diabetic nephropathy by binding to CD146 through noncanonical Wnt signaling. Cell Death Dis. 12:922021. View Article : Google Scholar : PubMed/NCBI

Pei D, Tian S, Bao Y, Zhang J, Xu D and Piao M: Protective effect of salidroside on streptozotocin-induced diabetic nephropathy by inhibiting oxidative stress and inflammation in rats via the Akt/GSK-3β signalling pathway. Pharm Biol. 60:1732–1738. 2022. View Article : Google Scholar : PubMed/NCBI

Han X, Wei J, Zheng R, Tu Y, Wang M, Chen L, Xu Z, Zheng L, Zheng C, Shi Q, et al: Macrophage SHP2 deficiency alleviates diabetic nephropathy via suppression of MAPK/NF-κB-dependent inflammation. Diabetes. 73:780–796. 2024. View Article : Google Scholar : PubMed/NCBI

Li J, Zhang J, Zhao X and Tian L: MSU crystallization promotes fibroblast proliferation and renal fibrosis in diabetic nephropathy via the ROS/SHP2/TGFβ pathway. Sci Rep. 14:202512024. View Article : Google Scholar

Wei TT, Yang LT, Guo F, Tao SB, Cheng L, Huang RS, Ma L and Fu P: Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy. Acta Pharmacol Sin. 42:252–263. 2021. View Article : Google Scholar

Yang WX, Liu Y, Zhang SM, Wang HF, Liu YF, Liu JL, Li XH, Zeng MR, Han YZ, Liu FY, et al: Epac activation ameliorates tubulointerstitial inflammation in diabetic nephropathy. Acta Pharmacol Sin. 43:659–671. 2022. View Article : Google Scholar

Reddy MA, Sumanth P, Lanting L, Yuan H, Wang M, Mar D, Alpers CE, Bomsztyk K and Natarajan R: Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice. Kidney Int. 85:362–373. 2014. View Article : Google Scholar :

Huang J, Wan D, Li J, Chen H, Huang K and Zheng L: Histone acetyltransferase PCAF regulates inflammatory molecules in the development of renal injury. Epigenetics. 10:62–72. 2015. View Article : Google Scholar

Pandey A and Gaikwad AB: Compound 21 and telmisartan combination mitigates type 2 diabetic nephropathy through amelioration of caspase mediated apoptosis. Biochem Biophys Res Commun. 487:827–833. 2017. View Article : Google Scholar : PubMed/NCBI

Nicholas SB, Aguiniga E, Ren Y, Kim J, Wong J, Govindarajan N, Noda M, Wang W, Kawano Y, Collins A and Hsueh WA: Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. Kidney Int. 67:1297–1307. 2005. View Article : Google Scholar : PubMed/NCBI

Chen H, Li J, Jiao L, Petersen RB, Li J, Peng A, Zheng L and Huang K: Apelin inhibits the development of diabetic nephropathy by regulating histone acetylation in Akita mouse. J Physiol. 592:505–521. 2014. View Article : Google Scholar

Du YG, Wang LP, Qian JW, Zhang KN and Chai KF: Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats. Chin J Integr Med. 22:910–917. 2016. View Article : Google Scholar

Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K and Koya D: Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: A model of type 2 diabetes. Exp Diabetes Res. 2011:9081852011. View Article : Google Scholar : PubMed/NCBI

Du YG, Zhang KN, Gao ZL, Dai F, Wu XX and Chai KF: Tangshen formula improves inflammation in renal tissue of diabetic nephropathy through SIRT1/NF-κB pathway. Exp Ther Med. 15:2156–2164. 2018.PubMed/NCBI

Liu HW, Kao HH and Wu CH: Exercise training upregulates SIRT1 to attenuate inflammation and metabolic dysfunction in kidney and liver of diabetic db/db mice. Nutr Metab (Lond). 16:222019. View Article : Google Scholar : PubMed/NCBI

Li X, Liu J, Lu L, Huang T, Hou W, Wang F, Yu L, Wu F, Qi J, Chen X, et al: Sirt7 associates with ELK1 to participate in hyperglycemia memory and diabetic nephropathy via modulation of DAPK3 expression and endothelial inflammation. Transl Res. 247:99–116. 2022. View Article : Google Scholar : PubMed/NCBI

Sankrityayan H, Kale A, Shelke V and Gaikwad AB: Cyproheptadine, a SET7/9 inhibitor, reduces hyperglycaemia-induced ER stress alleviating inflammation and fibrosis in renal tubular epithelial cells. Arch Physiol Biochem. 130:411–419. 2024. View Article : Google Scholar

Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME and El-Osta A: Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes. 58:1229–1236. 2009. View Article : Google Scholar : PubMed/NCBI

Wang F, Hou W, Li X, Lu L, Huang T, Zhu M and Miao C: SETD8 cooperates with MZF1 to participate in hyperglycemia-induced endothelial inflammation via elevation of WNT5A levels in diabetic nephropathy. Cell Mol Biol Lett. 27:302022. View Article : Google Scholar : PubMed/NCBI

Hou W, Lu L, Li X, Sun M, Zhu M and Miao C: c-Myc participates in high glucose-mediated endothelial inflammation via upregulation of IRAK1 expression in diabetic nephropathy. Cell Signal. 92:1102632022. View Article : Google Scholar : PubMed/NCBI

Huang T, Li X, Wang F, Lu L, Hou W, Zhu M and Miao C: The CREB/KMT5A complex regulates PTP1B to modulate high glucose-induced endothelial inflammatory factor levels in diabetic nephropathy. Cell Death Dis. 12:3332021. View Article : Google Scholar : PubMed/NCBI

Wang Y, Xu J and Cheng Z: YAP1 promotes high glucose-induced inflammation and extracellular matrix deposition in glomerular mesangial cells by modulating NF-κB/JMJD3 pathway. Exp Ther Med. 22:13492021. View Article : Google Scholar

Zheng W, Guo J and Liu ZS: Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: An epigenetic perspective. Clin Epigenetics. 13:872021. View Article : Google Scholar : PubMed/NCBI

Zhao Y, Fan S, Zhu H, Zhao Q, Fang Z, Xu D, Lin W, Lin L, Hu X, Wu G, et al: Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury. Nat Commun. 15:54412024. View Article : Google Scholar : PubMed/NCBI

Wang B, Dai Z, Gao Q, Liu Y, Gu G and Zheng H: Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome. Biochem Biophys Res Commun. 594:131–138. 2022. View Article : Google Scholar : PubMed/NCBI

Wu W, Huang XR, You Y, Xue L, Wang XJ, Meng X, Lin X, Shen J, Yu X, Lan HY and Chen H: Latent TGF-β1 protects against diabetic kidney disease via Arkadia/Smad7 signaling. Int J Biol Sci. 17:3583–3594. 2021. View Article : Google Scholar

Zhang X, Wang S, Chong N, Chen D, Shu J, Sun J, Sun Z, Wang R, Wang Q and Xu Y: GDF-15 alleviates diabetic nephropathy via inhibiting NEDD4L-mediated IKK/NF-κB signalling pathways. Int Immunopharmacol. 128:1114272024. View Article : Google Scholar

Chen K, Chen J, Wang L, Yang J, Xiao F, Wang X, Yuan J, Wang L and He Y: Parkin ubiquitinates GATA4 and attenuates the GATA4/GAS1 signaling and detrimental effects on diabetic nephropathy. FASEB J. 34:8858–8875. 2020. View Article : Google Scholar : PubMed/NCBI

Guo F, Song Y, Wu L, Zhao Y, Ma X, Wang J, Shao M, Ji H, Huang F, Fan X, et al: SUMO specific peptidase 6 regulates the crosstalk between podocytes and glomerular endothelial cells in diabetic kidney disease. Biochim Biophys Acta Mol Basis Dis. 1869:1666852023. View Article : Google Scholar : PubMed/NCBI

Huang W, Xu L, Zhou X, Gao C, Yang M, Chen G, Zhu J, Jiang L, Gan H, Gou F, et al: High glucose induces activation of NF-κB inflammatory signaling through IκBα sumoylation in rat mesangial cells. Biochem Biophys Res Commun. 438:568–574. 2013. View Article : Google Scholar : PubMed/NCBI

Huang W, Liang Y, Dong J, Zhou L, Gao C, Jiang C, Chen M, Long Y and Xu Y: SUMO E3 Ligase PIASy mediates high glucose-induced activation of NF-κB inflammatory signaling in rat mesangial cells. Mediators Inflamm. 2017:16851942017. View Article : Google Scholar

Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, Giardino I, Suske G, Rabbani N, Thornalley PJ, Sarthy VP, et al: High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem. 282:31038–31045. 2007. View Article : Google Scholar : PubMed/NCBI

He Y, Xie Y, Zhou T, Li D, Cheng X, Yang P, Luo C, Liu Y, Guo M, Wan Q, et al: Sodium crotonate alleviates diabetic kidney disease partially via the histone crotonylation pathway. Inflammation. 48:254–275. 2025. View Article : Google Scholar

Zhang XX, Liu Y, Xu SS, Yang R, Jiang CH, Zhu LP, Xu YY, Pan K, Zhang J and Yin ZQ: Asiatic acid from Cyclocarya paliurus regulates the autophagy-lysosome system via directly inhibiting TGF-β type I receptor and ameliorates diabetic nephropathy fibrosis. Food Funct. 13:5536–5546. 2022. View Article : Google Scholar : PubMed/NCBI

Zhu QQ, Yang XY, Zhang XJ, Yu CJ, Pang QQ, Huang YW, Wang XJ and Sheng J: EGCG targeting Notch to attenuate renal fibrosis via inhibition of TGFβ/Smad3 signaling pathway activation in streptozotocin-induced diabetic mice. Food Funct. 11:9686–9695. 2020. View Article : Google Scholar : PubMed/NCBI

Das F, Ghosh-Choudhury N, Maity S, Kasinath BS and Choudhury GG: Oncoprotein DJ-1 interacts with mTOR complexes to effect transcription factor Hif1α-dependent expression of collagen I (α2) during renal fibrosis. J Biol Chem. 298:1022462022. View Article : Google Scholar

Wu L, Liu C, Chang DY, Zhan R, Zhao M, Man Lam S, Shui G, Zhao MH, Zheng L and Chen M: The attenuation of diabetic nephropathy by annexin A1 via regulation of lipid metabolism through the AMPK/PPARα/CPT1b pathway. Diabetes. 70:2192–2203. 2021. View Article : Google Scholar : PubMed/NCBI

Cho W, Oh H, Choi SW, Abd El-Aty AM, Birdal O, Jeong JH, Song JH and Jung TW: CTRP4 attenuates apoptosis and epithelial-mesenchymal transition markers in podocytes through an AMPK/autophagy-dependent pathway. Biochem Biophys Res Commun. 682:104–110. 2023. View Article : Google Scholar : PubMed/NCBI

Han Y, Xiong S, Zhao H, Yang S, Yang M, Zhu X, Jiang N, Xiong X, Gao P, Wei L, et al: Lipophagy deficiency exacerbates ectopic lipid accumulation and tubular cells injury in diabetic nephropathy. Cell Death Dis. 12:10312021. View Article : Google Scholar : PubMed/NCBI

Chen J, Chen KH, Wang LM, Luo J, Zheng QY and He YN: Decoy receptor 2 mediates the apoptosis-resistant phenotype of senescent renal tubular cells and accelerates renal fibrosis in diabetic nephropathy. Cell Death Dis. 13:5222022. View Article : Google Scholar : PubMed/NCBI

Li J, Jin S, Barati MT, Rane S, Lin Q, Tan Y, Cai L and Rane MJ: ERK and p38 MAPK inhibition controls NF-E2 degradation and profibrotic signaling in renal proximal tubule cells. Life Sci. 287:1200922021. View Article : Google Scholar : PubMed/NCBI

Zhang L, Zang CS, Chen B, Wang Y, Xue S and Wu MY: Renalase regulates renal tubular injury in diabetic nephropathy via the p38MAPK signaling pathway. FASEB J. 37:e231882023. View Article : Google Scholar : PubMed/NCBI

Wen Y, Liu Y, Huang Q, Liu R, Liu J, Zhang F, Liu S and Jiang Y: Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway. Phytomedicine. 95:1538562022. View Article : Google Scholar

Shin JH, Kim KM, Jeong JU, Shin JM, Kang JH, Bang K and Kim JH: Nrf2-heme oxygenase-1 attenuates high-glucose-induced epithelial-to-mesenchymal transition of renal tubule cells by inhibiting ROS-Mediated PI3K/Akt/GSK-3β signaling. J Diabetes Res. 2019:25101052019. View Article : Google Scholar

Zeng J, Liang L, Chen R, Li C, Pan L, Wen M, Lv D, Liu M, Xu Z and Huang H: Fraxin represses NF-κB pathway via inhibiting the activation of epidermal growth factor receptor to ameliorate diabetic renal tubulointerstitial fibrosis. Eur J Pharmacol. 955:1759152023. View Article : Google Scholar

Ram C, Gairola S, Verma S, Mugale MN, Bonam SR, Murty US and Sahu BD: Biochanin A ameliorates nephropathy in high-fat diet/streptozotocin-induced diabetic rats: Effects on NF-kB/NLRP3 axis, pyroptosis, and fibrosis. Antioxidants (Basel). 12:10522023. View Article : Google Scholar : PubMed/NCBI

Qu X, Zhai B, Liu Y, Chen Y, Xie Z, Wang Q, Wu Y, Liu Z, Chen J, Mei S, et al: Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells. Biomed Pharmacother. 150:1129982022. View Article : Google Scholar : PubMed/NCBI

Gu LY, Yun-Sun, Tang HT and Xu ZX: Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway. J Ethnopharmacol. 281:1135482021. View Article : Google Scholar

Duan YR, Chen BP, Chen F, Yang SX, Zhu CY, Ma YL, Li Y and Shi J: LncRNA lnc-ISG20 promotes renal fibrosis in diabetic nephropathy by inducing AKT phosphorylation through miR-486-5p/NFAT5. J Cell Mol Med. 25:4922–4937. 2021. View Article : Google Scholar : PubMed/NCBI

Subathra M, Korrapati M, Howell LA, Arthur JM, Shayman JA, Schnellmann RG and Siskind LJ: Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells. Am J Physiol Renal Physiol. 309:F204–F215. 2015. View Article : Google Scholar : PubMed/NCBI

Hsu YC, Ho C, Shih YH, Ni WC, Li YC, Chang HC and Lin CL: Knockout of KLF10 ameliorated diabetic renal fibrosis via downregulation of DKK-1. Molecules. 27:26442022. View Article : Google Scholar : PubMed/NCBI

Chen X, Xiao J, Tao D, Liang Y, Chen S, Shen L, Li S, Zheng Z, Zeng Y, Luo C, et al: Metadherin orchestrates PKA and PKM2 to activate β-catenin signaling in podocytes during proteinuric chronic kidney disease. Transl Res. 266:68–83. 2024. View Article : Google Scholar

Chen G, Wang T, Uttarwar L, vanKrieken R, Li R, Chen X, Gao B, Ghayur A, Margetts P and Krepinsky JC: SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells. J Mol Cell Biol. 6:516–530. 2014. View Article : Google Scholar : PubMed/NCBI

Noh H, Oh EY, Seo JY, Yu MR, Kim YO, Ha H and Lee HB: Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol. 297:F729–F739. 2009. View Article : Google Scholar : PubMed/NCBI

Zhang L, Chen L, Gao C, Chen E, Lightle AR, Foulke L, Zhao B, Higgins PJ and Zhang W: Loss of histone H3 K79 methyltransferase Dot1l facilitates kidney fibrosis by upregulating endothelin 1 through histone deacetylase 2. J Am Soc Nephrol. 31:337–349. 2020. View Article : Google Scholar

Zheng Z, Zhang S, Chen J, Zou M, Yang Y, Lu W, Ren S, Wang X, Dong W, Zhang Z, et al: The HDAC2/SP1/miR-205 feedback loop contributes to tubular epithelial cell extracellular matrix production in diabetic kidney disease. Clin Sci (Lond). 136:223–238. 2022. View Article : Google Scholar : PubMed/NCBI

Feng J, Bao L, Wang X, Li H, Chen Y, Xiao W, Li Z, Xie L, Lu W, Jiang H, et al: Low expression of HIV genes in podocytes accelerates the progression of diabetic kidney disease in mice. Kidney Int. 99:914–925. 2021. View Article : Google Scholar

Wang Y, Zuo B, Wang N, Li S, Liu C and Sun D: Calcium dobesilate mediates renal interstitial fibrosis and delay renal peritubular capillary loss through Sirt1/p53 signaling pathway. Biomed Pharmacother. 132:1107982020. View Article : Google Scholar : PubMed/NCBI

Zhong X and Zhang J: RUNX3-activated apelin signaling inhibits cell proliferation and fibrosis in diabetic nephropathy by regulation of the SIRT1/FOXO pathway. Diabetol Metab Syndr. 16:1672024. View Article : Google Scholar : PubMed/NCBI

Srivastava SP, Li J, Takagaki Y, Kitada M, Goodwin JE, Kanasaki K and Koya D: Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys. iScience. 24:1023902021. View Article : Google Scholar : PubMed/NCBI

Wang X, Ji T, Li X, Qu X and Bai S: FOXO3a protects against kidney injury in type II diabetic nephropathy by promoting Sirt6 expression and inhibiting Smad3 Acetylation. Oxid Med Cell Longev. 2021:55657612021. View Article : Google Scholar : PubMed/NCBI

Yang G, Jin L, Zheng D, Tang X, Yang J, Fan L and Xie X: Fucoxanthin alleviates oxidative stress through Akt/Sirt1/FoxO3α signaling to inhibit HG-induced renal fibrosis in GMCs. Mar Drugs. 17:7022019. View Article : Google Scholar

Jia Y, Reddy MA, Das S, Oh HJ, Abdollahi M, Yuan H, Zhang E, Lanting L, Wang M and Natarajan R: Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-β1-induced gene expression in mesangial cells and diabetic kidney. J Biol Chem. 294:12695–12707. 2019. View Article : Google Scholar : PubMed/NCBI

Zhang L, Zhao S and Zhu Y: Long noncoding RNA growth arrest-specific transcript 5 alleviates renal fibrosis in diabetic nephropathy by downregulating matrix metalloproteinase 9 through recruitment of enhancer of zeste homolog 2. FASEB J. 34:2703–2714. 2020. View Article : Google Scholar : PubMed/NCBI

Fang N and Li P: O-linked N-acetylglucosaminyltransferase OGT inhibits diabetic nephropathy by stabilizing histone methyltransferases EZH2 via the HES1/PTEN axis. Life Sci. 274:1192262021. View Article : Google Scholar : PubMed/NCBI

Das F, Bera A, Ghosh-Choudhury N, Sataranatarajan K, Kamat A, Kasinath BS and Choudhury GG: High glucose-stimulated enhancer of zeste homolog-2 (EZH2) forces suppression of deptor to cause glomerular mesangial cell pathology. Cell Signal. 86:1100722021. View Article : Google Scholar : PubMed/NCBI

Chen YX, Zhu SY, Huang C, Xu CY, Fang XD and Tu WP: LncRNA Dlx6os1 accelerates diabetic nephropathy progression by epigenetically repressing SOX6 via recruiting EZH2. Kidney Blood Press Res. 47:177–184. 2022. View Article : Google Scholar : PubMed/NCBI

Li X, Li C, Li X, Cui P, Li Q, Guo Q, Han H, Liu S and Sun G: Involvement of histone lysine methylation in p21 gene expression in rat kidney in vivo and rat mesangial cells in vitro under diabetic conditions. J Diabetes Res. 2016:38532422016. View Article : Google Scholar : PubMed/NCBI

Goru SK and Gaikwad AB: Novel reno-protective mechanism of Aspirin involves H2AK119 monoubiquitination and Set7 in preventing type 1 diabetic nephropathy. Pharmacol Rep. 70:497–502. 2018. View Article : Google Scholar : PubMed/NCBI

Yuan H, Reddy MA, Deshpande S, Jia Y, Park JT, Lanting LL, Jin W, Kato M, Xu ZG, Das S and Natarajan R: Epigenetic histone modifications involved in profibrotic gene regulation by 12/15-lipoxygenase and its oxidized lipid products in diabetic nephropathy. Antioxid Redox Signal. 24:361–375. 2016. View Article : Google Scholar

Maxwell S, Okabe J, Kaipananickal H, Rodriguez H, Khurana I, Al-Hasani K, Chow BSM, Pitsillou E, Karagiannis TC, Jandeleit-Dahm K, et al: Set7 methyltransferase and phenotypic switch in diabetic glomerular endothelial cells. J Am Soc Nephrol. 35:733–748. 2024. View Article : Google Scholar : PubMed/NCBI

Li X, Lu L, Hou W, Wang F, Huang T, Meng Z and Zhu M: The SETD8/ELK1/bach1 complex regulates hyperglycaemia-mediated EndMT in diabetic nephropathy. J Transl Med. 20:1472022. View Article : Google Scholar : PubMed/NCBI

Lu L, Zhong Z, Gu J, Nan K, Zhu M and Miao C: ets1 associates with KMT5A to participate in high glucose-mediated EndMT via upregulation of PFN2 expression in diabetic nephropathy. Mol Med. 27:742021. View Article : Google Scholar : PubMed/NCBI

Lu L, Li X, Zhong Z, Zhou W, Zhou D, Zhu M and Miao C: KMT5A downregulation participated in High Glucose-mediated EndMT via upregulation of ENO1 expression in diabetic nephropathy. Int J Biol Sci. 17:4093–4107. 2021. View Article : Google Scholar : PubMed/NCBI

Chen YY, Peng XF, Liu GY, Liu JS, Sun L, Liu H, Xiao L and He LY: Protein arginine methyltranferase-1 induces ER stress and epithelial-mesenchymal transition in renal tubular epithelial cells and contributes to diabetic nephropathy. Biochim Biophys Acta Mol Basis Dis. 1865:2563–2575. 2019. View Article : Google Scholar : PubMed/NCBI

Bai S, Xiong X, Tang B, Ji T, Li X, Qu X and Li W: hsa-miR-199b-3p prevents the epithelial-mesenchymal transition and dysfunction of the renal tubule by regulating E-cadherin through targeting KDM6A in diabetic nephropathy. Oxid Med Cell Longev. 2021:88141632021. View Article : Google Scholar : PubMed/NCBI

Hung PH, Hsu YC, Chen TH, Ho C and Lin CL: The histone demethylase inhibitor GSK-J4 Is a therapeutic target for the kidney fibrosis of diabetic kidney disease via DKK1 Modulation. Int J Mol Sci. 23:94072022. View Article : Google Scholar : PubMed/NCBI

Shao J, Xu H, Wu X and Xu Y: Epigenetic activation of CTGF transcription by high glucose in renal tubular epithelial cells is mediated by myocardin-related transcription factor A. Cell Tissue Res. 379:549–559. 2020. View Article : Google Scholar

Dong L, Yu L and Zhong J: Histone lysine-specific demethylase 1 induced renal fibrosis via decreasing sirtuin 3 expression and activating TGF-β1/Smad3 pathway in diabetic nephropathy. Diabetol Metab Syndr. 14:22022. View Article : Google Scholar

Morschhauser F, Tilly H, Chaidos A, McKay P, Phillips T, Assouline S, Batlevi CL, Campbell P, Ribrag V, Damaj GL, et al: Tazemetostat for patients with relapsed or refractory follicular lymphoma: An open-label, single-arm, multicentre, phase 2 trial. Lancet Oncol. 21:1433–1442. 2020. View Article : Google Scholar : PubMed/NCBI

Huang S, Wang Z, Zhou J, Huang J, Zhou L, Luo J, Wan YY, Long H and Zhu B: EZH2 inhibitor GSK126 suppresses antitumor immunity by driving production of myeloid-derived suppressor cells. Cancer Res. 79:2009–2020. 2019. View Article : Google Scholar : PubMed/NCBI

Chen Y, Dai R, Cheng M, Wang W, Liu C, Cao Z, Ge Y, Wang Y and Zhang L: Status and role of the ubiquitin-proteasome system in renal fibrosis. Biomed Pharmacother. 178:1172102024. View Article : Google Scholar : PubMed/NCBI

Lv K, Li Q, Jiang N and Chen Q: Role of TRIM29 in disease: What is and is not known. Int Immunopharmacol. 147:1139832025. View Article : Google Scholar : PubMed/NCBI

Chen Q, Gao C, Wang M, Fei X and Zhao N: TRIM18-regulated STAT3 signaling pathway via PTP1B promotes renal epithelial-mesenchymal transition, inflammation, and fibrosis in diabetic kidney disease. Front Physiol. 12:7095062021. View Article : Google Scholar : PubMed/NCBI

Li Y, Ren D, Shen Y, Zheng X and Xu G: Altered DNA methylation of TRIM13 in diabetic nephropathy suppresses mesangial collagen synthesis by promoting ubiquitination of CHOP. EBioMedicine. 51:1025822020. View Article : Google Scholar : PubMed/NCBI

Chen Z, Sun X, Chen Q, Lan T, Huang K, Xiao H, Lin Z, Yang Y, Liu P and Huang H: Connexin32 ameliorates renal fibrosis in diabetic mice by promoting K48-linked NADPH oxidase 4 polyubiquitination and degradation. Br J Pharmacol. 177:145–160. 2020. View Article : Google Scholar

Lin Z, Li S, Xiao H, Xu Z, Li C, Zeng J, Wang S, Liu Z and Huang H: The degradation of TGR5 mediated by Smurf1 contributes to diabetic nephropathy. Cell Rep. 42:1128512023. View Article : Google Scholar : PubMed/NCBI

Kim D, Nam GY, Seo E and Jun HS: Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells. J Biomed Sci. 29:312022. View Article : Google Scholar : PubMed/NCBI

Yang Y, Xiao H, Lin Z, Chen R, Li S, Li C, Sun X, Hei Z, Gong W and Huang H: The ubiquitination of CKIP-1 mediated by Src aggravates diabetic renal fibrosis (original article). Biochem Pharmacol. 206:1153392022. View Article : Google Scholar : PubMed/NCBI

Zhao X, He X, Wei W and Huang K: USP22 aggravated diabetic renal tubulointerstitial fibrosis progression through deubiquitinating and stabilizing Snail1. Eur J Pharmacol. 947:1756712023. View Article : Google Scholar : PubMed/NCBI

Huang K and Zhao X: USP9X prevents AGEs-induced upregulation of FN and TGF-β1 through activating Nrf2-ARE pathway in rat glomerular mesangial cells. Exp Cell Res. 393:1121002020. View Article : Google Scholar

Liu Z, Nan P, Gong Y, Tian L, Zheng Y and Wu Z: Endoplasmic reticulum stress-triggered ferroptosis via the XBP1-Hrd1-Nrf2 pathway induces EMT progression in diabetic nephropathy. Biomed Pharmacother. 164:1148972023. View Article : Google Scholar : PubMed/NCBI

Sun XH, Xiao HM, Zhang M, Lin ZY, Yang Y, Chen R, Liu PQ, Huang KP and Huang HQ: USP9X deubiquitinates connexin43 to prevent high glucose-induced epithelial-to-mesenchymal transition in NRK-52E cells. Biochem Pharmacol. 188:1145622021. View Article : Google Scholar : PubMed/NCBI

Chang L, Wang Q, Ju J, Li Y, Cai Q, Hao L and Zhou Y: Magnoflorine ameliorates inflammation and fibrosis in rats with diabetic nephropathy by mediating the stability of lysine-specific demethylase 3A. Front Physiol. 11:5804062020. View Article : Google Scholar

Wang Y, Mao Y, Zhang X, Liu H, Peng W, Liang L, Shi M, Xiao Y, Zhang Y, Zhang F, et al: TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein. Life Sci. 228:1–10. 2019. View Article : Google Scholar : PubMed/NCBI

Peng W, Zhou X, Xu T, Mao Y, Zhang X, Liu H, Liang L, Liu L, Liu L, Xiao Y, et al: BMP-7 ameliorates partial epithelial-mesenchymal transition by restoring SnoN protein level via Smad1/5 pathway in diabetic kidney disease. Cell Death Dis. 13:2542022. View Article : Google Scholar : PubMed/NCBI

Gu C, Gao F, Zhang S, Kang L, Zhang W, Feng X, Liu J, Tian Y, Wei Q, Du Y, et al: Role of SUMOylation of STAT1 in tubular epithelial-mesenchymal transition induced by high glucose. Mol Med Rep. 27:422023. View Article : Google Scholar

Zhou X, Gao C, Huang W, Yang M, Chen G, Jiang L, Gou F, Feng H, Ai N and Xu Y: High glucose induces sumoylation of Smad4 via SUMO2/3 in mesangial cells. Biomed Res Int. 2014:7826252014. View Article : Google Scholar : PubMed/NCBI

Zhou XQ, Huang W, Xu Y and Yang MJ: High glucose induces sumoylation of Smad4 via SUMO2/3 in glomerular mesangial cells. Sichuan Da Xue Xue Bao Yi Xue Ban. 45:380–385. 2014.In Chinese. PubMed/NCBI

Park MJ, Kim DI, Lim SK, Choi JH, Han HJ, Yoon KC and Park SH: High glucose-induced O-GlcNAcylated carbohydrate response element-binding protein (ChREBP) mediates mesangial cell lipogenesis and fibrosis: The possible role in the development of diabetic nephropathy. J Biol Chem. 289:13519–13530. 2014. View Article : Google Scholar : PubMed/NCBI

Goldberg H, Whiteside C and Fantus IG: O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells. Am J Physiol Endocrinol Metab. 301:E713–E726. 2011. View Article : Google Scholar : PubMed/NCBI

Aluksanasuwan S, Plumworasawat S, Malaitad T, Chaiyarit S and Thongboonkerd V: High glucose induces phosphorylation and oxidation of mitochondrial proteins in renal tubular cells: A proteomics approach. Sci Rep. 10:58432020. View Article : Google Scholar : PubMed/NCBI

Veron D, Aggarwal PK, Li Q, Moeckel G, Kashgarian M and Tufro A: Podocyte VEGF-A knockdown induces diffuse glomerulosclerosis in diabetic and in eNOS knockout mice. Front Pharmacol. 12:7888862022. View Article : Google Scholar : PubMed/NCBI

Veron D, Aggarwal PK, Velazquez H, Kashgarian M, Moeckel G and Tufro A: Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice. J Am Soc Nephrol. 25:1814–1824. 2014. View Article : Google Scholar : PubMed/NCBI

Zhang X, Chen J, Lin R, Huang Y, Wang Z, Xu S, Wang L, Chen F, Zhang J, Pan K and Yin Z: Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la/KLF5 pathway. Redox Biol. 75:1032462024. View Article : Google Scholar : PubMed/NCBI

Hong J, Xu H, Yu L, Yu Z, Chen X, Meng Z, Zhu J, Li J and Zhu M: AARS1-mediated lactylation of H3K18 and STAT1 promotes ferroptosis in diabetic nephropathy. Cell Death Differ. Sep 23–2025.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI

Luo W, Yu Y, Wang H, Liu K, Wang Y, Huang M, Xuan C, Li Y and Qi J: Up-regulation of MMP-2 by histone H3K9 β-hydroxybutyrylation to antagonize glomerulosclerosis in diabetic rat. Acta Diabetol. 57:1501–1509. 2020. View Article : Google Scholar : PubMed/NCBI

Lyu LX, Hu MY, Lei YQ, Pan SK, Liu DW, Zhou SJ and Liu ZS: The mechanism of β-hydroxybutyrylation in G6PDX regulated by β-hydroxybutyric acid on alleviating podocyte injury induced by high glucose. Zhonghua Yi Xue Za Zhi. 105:900–906. 2025.In Chinese. PubMed/NCBI

Akimoto Y, Yan K, Miura Y, Tsumoto H, Toda T, Fukutomi T, Sugahara D, Kudo A, Arai T, Chiba Y, et al: O-GlcNAcylation and phosphorylation of β-actin Ser199 in diabetic nephropathy. Am J Physiol Renal Physiol. 317:F1359–F1374. 2019. View Article : Google Scholar

Goru SK, Kadakol A, Pandey A, Malek V, Sharma N and Gaikwad AB: Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis. Biochem J. 473:3937–3949. 2016. View Article : Google Scholar : PubMed/NCBI

Li XQ, Jin B, Liu SX, Zhu Y, Li N, Zhang QY, Wan C, Feng Y, Xing YX, Ma KL, et al: Neddylation of RhoA impairs its protein degradation and promotes renal interstitial fibrosis progression in diabetic nephropathy. Acta Pharmacol Sin. 46:1692–1705. 2025. View Article : Google Scholar : PubMed/NCBI

Qu P, Li L, Jin Q, Liu D, Qiao Y, Zhang Y, Sun Q, Ran S, Li Z, Liu T and Peng L: Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review). Int J Mol Med. 54:1042024. View Article : Google Scholar : PubMed/NCBI

Hu H, Ji R, Hao Y, Liu Z, Yang J, Cao Y and Yang Q: XIAP-ULK1-mediated mitophagy modulates carnitine metabolism to mitigate diabetic kidney disease. Autophagy. 22:207–228. 2026. View Article : Google Scholar

Memarian E, t Hart LM, Slieker RC, Lemmers RFL, van der Heijden AA, Rutters F, Nijpels G, Schoep E, Lieverse AG, Sijbrands EJG, et al: Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes. BMJ Open Diabetes Res Care. 9:e0023452021. View Article : Google Scholar : PubMed/NCBI

Azushima K, Kovalik JP, Yamaji T, Ching J, Chng TW, Guo J, Liu JJ, Nguyen M, Sakban RB, George SE, et al: Abnormal lactate metabolism is linked to albuminuria and kidney injury in diabetic nephropathy. Kidney Int. 104:1135–1149. 2023. View Article : Google Scholar : PubMed/NCBI

Chen H, Du P, Jiang T, Li Y, Li Y, Liu Y, Yang B, Kang J, Duan J, Ma Y, et al: Identification of potential biomarkers for diabetic nephropathy via UPLC-MS/MS-based metabolomics. Front Endocrinol (Lausanne). 16:15816912025. View Article : Google Scholar : PubMed/NCBI

Zhang JY, Wu J, Chen ZH, Liu SY, Li P and Chen DQ: Acetylation in renal physiology and pathophysiology. Front Pharmacol. 16:16601092025. View Article : Google Scholar : PubMed/NCBI

Siddhi J, Sherkhane B, Kalavala AK, Arruri V, Velayutham R and Kumar A: Melatonin prevents diabetes-induced nephropathy by modulating the AMPK/SIRT1 axis: Focus on autophagy and mitochondrial dysfunction. Cell Biol Int. 46:2142–2157. 2022. View Article : Google Scholar : PubMed/NCBI

Gu W, Wang X, Zhao H, Geng J, Li X, Zheng K, Guan Y, Hou X, Wang C and Song G: Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway. Eur J Pharmacol. 918:1747762022. View Article : Google Scholar : PubMed/NCBI

Ren H, Shao Y, Wu C, Ma X, Lv C and Wang Q: Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway. Mol Cell Endocrinol. 500:1106282020. View Article : Google Scholar

Qi B, Chen Y, Chai S, Lu X and Kang L: O-linked β-N-acetylglucosamine (O-GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy. Diabet Med. 42:e154362025. View Article : Google Scholar

Fontecha-Barriuso M, Martin-Sanchez D, Ruiz-Andres O, Poveda J, Sanchez-Niño MD, Valiño-Rivas L, Ruiz-Ortega M, Ortiz A and Sanz AB: Targeting epigenetic DNA and histone modifications to treat kidney disease. Nephrol Dial Transplant. 33:1875–1886. 2018. View Article : Google Scholar : PubMed/NCBI

Matsui S, Yamamoto T, Takabatake Y, Takahashi A, Namba-Hamano T, Matsuda J, Minami S, Sakai S, Yonishi H, Nakamura J, et al: Defective autophagy and AMPK inactivation drive ferroptosis in diabetic kidney disease. Diabetologia. Nov 28–2025.Epub ahead of print. PubMed/NCBI

Zhou X, Zang X, Ponnusamy M, Masucci MV, Tolbert E, Gong R, Zhao TC, Liu N, Bayliss G, Dworkin LD and Zhuang S: Enhancer of zeste homolog 2 inhibition attenuates renal fibrosis by maintaining Smad7 and phosphatase and tensin homolog expression. J Am Soc Nephrol. 27:2092–2108. 2016. View Article : Google Scholar

Cao J, Chen G, Qiu L, Zhang L, Jiang M, Cheng Y, Zhang Q, Liu L, Li P, Shuang Y, et al: Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: A multicentre, single-arm, phase 2 study. EClinicalMedicine. 87:1033992025. View Article : Google Scholar : PubMed/NCBI

Zinzani PL, Izutsu K, Mehta-Shah N, Barta SK, Ishitsuka K, Córdoba R, Kusumoto S, Bachy E, Cwynarski K, Gritti G, et al: Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): A multicentre, open-label, single-arm, phase 2 study. Lancet Oncol. 25:1602–1613. 2024. View Article : Google Scholar : PubMed/NCBI

Maruyama D, Jacobsen E, Porcu P, Allen P, Ishitsuka K, Kusumoto S, Narita T, Tobinai K, Foss F, Tsukasaki K, et al: Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: A first-in-human, multicentre, open-label, single-arm, phase 1 study. Lancet Oncol. 25:1589–1601. 2024. View Article : Google Scholar : PubMed/NCBI

Rong QX, Chen MT, Yang W, Huang RQ, Shu DT, Zhang Y, Xue C, Cai YC, An X, Li HF and Shi YX: Chidamide (a Histone Deacetylase Inhibitor) Plus abiraterone in metastatic castration-resistant prostate cancer (mCRPC): A phase Ib trial. MedComm (2020). 6:e704702025. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Chen X, Yuan L, Zhang Y, Wu J, Guo N, Chen X and Liu J: Down-regulation of IRAK1 attenuates podocyte apoptosis in diabetic nephropathy through PI3K/Akt signaling pathway. Biochem Biophys Res Commun. 506:529–535. 2018. View Article : Google Scholar : PubMed/NCBI

Chen J, Wang X, He Q, Yang HC, Fogo AB and Harris RC: Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury. Kidney Int. 105:1200–1211. 2024. View Article : Google Scholar : PubMed/NCBI

Zhan M, Usman I, Yu J, Ruan L, Bian X, Yang J, Yang S, Sun L and Kanwar YS: Perturbations in mitochondrial dynamics by p66Shc lead to renal tubular oxidative injury in human diabetic nephropathy. Clin Sci (Lond). 132:1297–1314. 2018. View Article : Google Scholar : PubMed/NCBI

Ma Y, Yan R, Wan Q, Lv B, Yang Y, Lv T and Xin W: Inhibitor of growth 2 regulates the high glucose-induced cell cycle arrest and epithelial-to-mesenchymal transition in renal proximal tubular cells. J Physiol Biochem. 76:373–382. 2020. View Article : Google Scholar : PubMed/NCBI

Du L, Qian X, Li Y, Li XZ, He LL, Xu L, Liu YQ, Li CC, Ma P, Shu FL, et al: Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy. Acta Pharmacol Sin. 42:242–251. 2021. View Article : Google Scholar

Xu H, Wu X, Qin H, Tian W, Chen J, Sun L, Fang M and Xu Y: Myocardin-related transcription factor a epigenetically regulates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol. 26:1648–1660. 2015. View Article : Google Scholar

Li Y, Hu Q, Li C, Liang K, Xiang Y, Hsiao H, Nguyen TK, Park PK, Egranov SD, Ambati CR, et al: PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease. J Clin Invest. 129:1129–1151. 2019. View Article : Google Scholar : PubMed/NCBI

Pontrelli P, Conserva F, Menghini R, Rossini M, Stasi A, Divella C, Casagrande V, Cinefra C, Barozzino M, Simone S, et al: Inhibition of lysine 63 ubiquitination prevents the progression of renal fibrosis in diabetic DBA/2J mice. Int J Mol Sci. 22:51942021. View Article : Google Scholar : PubMed/NCBI